TrialGenome medicine2018

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

Elen Kristine Höglander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.